Thailand FDA periodically releases list of of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of clinical trials. Under Thailand regulatory system, approved ethics committees serve as the main point of approvals for initiating clinical trials in the country. This has been explained in our previous articles (see Part I and Part II), […]

Read More →

Case record form (CRF) is a wonderful and necessary tool used in clinical trials to collect data from each participating patient. CRF (also, referred as case report form) have historically been on paper (unlike electronic ones these days). Traditionally, something like carbon copy paper have been used, such that one sheet can be added to […]

Read More →

Philippines is a country with large population and wide network of hospitals, medical centers and health care professionals, making it a fertile platform for conducting clinical trials. In clinical trials, Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Currently, a total of 882 clinical trials […]

Read More →

Pancreatitis, inflammation of pancreas, is the leading cause of GI related hospitalizations in USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In 2015, […]

Read More →

What do you call a country with quality research facilities, efficient ethics and regulatory framework, diverse participant recruitment pool, research tax incentives and flexibility in conducting research? Some call it a dream destination, others Australia! It’s a country that has the world’s best researchers and health professionals, boasts a world-class research infrastructure and high standards of […]

Read More →

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous or granulocytic leukaemia. [1] Causes of AML The causes of AML remain […]

Read More →

Vietnam, known for its tourism destination, now is also a destination for clinical trials and research. With a sizeable population of 85 million, Vietnam provides a vast pool of participants, healthcare professionals and strong doctor – patient relationships, which result in a greater retention rate. [1] Clinical Trials in Vietnam Since last few years, Vietnam […]

Read More →

A country with large pool of patients, highly skilled Investigators and supportive regulations to promote clinical research is a desired destination for any organisation to conduct Clinical Trials. India has a lot more to offer besides these advantages, enabling you to enjoy timely completion of trials and cost benefits. (It is estimated that India offers 35 […]

Read More →

Clinical trial feasibility is a process to evaluate the possibility of conducting a clinical study in a particular region, specific medical centers/site with an objective of optimum project completion in terms of timelines, targets and cost. This forms an integral and unavoidable step in beginning any clinical trial. A clinical trial feasibility is always facilitated […]

Read More →

Exploring the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies, requires considering many factors and areas. In first part of this series of article for Clinical Trials in United States, regulatory situation, site and investigators were discussed. In this part, we will be knowing about […]

Read More →